Dr. Cillian De Gascun:

It is difficult for me to give certainty around that. The drug companies suggest that they are already manufacturing their vaccine.

They are manufacturing their product on the basis that they believe it will be effective. This comes back to the importance of the scientific process and the data being published and made available so that we can all review them and see which groups were vaccinated and how well the vaccine worked in those settings. Again, we believe the data from phase 3 clinical trials will be available towards the end of November and we look forward to seeing what they tell us.